Latest Breaking News On - Chong kun dang pharma - Page 1 : vimarsana.com

South Korean Pharma Companies Focus on Osteoporosis Treatment Amid Aging Population

South Korean Pharma Companies Focus on Osteoporosis Treatment Amid Aging Population
koreabizwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from koreabizwire.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaSoult ukpyolsiAsahi kasei pharmaChong kun dang pharmaSamsung bioepisHealth insurance review assessment serviceDrug administrationKorea bizwireHealth insurance reviewAssessment serviceAsahi kaseiKun dang pharma

Innovent Biologics and Synaffix Expand ADC Collaboration Following Positive Preliminary Clinical Signal from Ongoing Phase 1 Study

/PRNewswire/ Synaffix B.V., a Lonza company (SIX: LONN) focused on commercializing its clinical-stage platform technology for the development of.

Noord hollandMicrotubule synstatinMicrotubule syntansineInnovent biologicsChong kun dang pharmaLepu biopharmaAdimab incyteEli lillyPrnewswire synaffixMd anderson cancer centerResearch at innoventInnovent biologics incPlatform technologyVice presidentCancer biologyMersana therapeutics

SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline

SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Noord hollandLepu biopharmaMicrotubule synstatinPrnewswire synaffixEli lillyInnovent biologicsMicrotubule syntansineChong kun dang pharmaRadek spisekPlatform technologyCapsules health ingredientsAntibody drug conjugateChief executive officerMersana therapeuticsShanghai miracogenKyowa kirin

SOTIO Further Expands Next-Generation ADC Platform with License to Synaffix s ADC Technology

SOTIO will leverage Synaffix’s antibody-drug conjugate platform for the design of up to three novel ADCs to address indications with high unmet medical needCollaboration bolsters SOTIO’s wider portfolio of differentiated immuno-oncology therapies tailored to address the specific challenges of solid tumorsSynaffix wi.

Eli lillyLepu biopharmaChong kun dang pharmaRadek spisekInnovent biologicsRichard kapsaMartin steegmaierMersana therapeuticsShanghai miracogenKyowa kirinEmergence therapeuticsHummingbird biosciences

Synaffix to Launch New ADC Technologies at the World ADC Conference in San Diego

Synaffix to Launch New ADC Technologies at the World ADC Conference in San Diego
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesNoord hollandMicrotubule syntansineEli lillyInnovent biologicsPrnewswire synaffixMicrotubule synstatinChong kun dang pharmaLepu biopharmaCapsules health ingredientsPlatform technologyGlycoconnect highChief scientific officerMersana therapeuticsShanghai miracogen